Moreover, immunofluorescence staining with antibodies against E-cadherin and N-cadherin, which are Epithelial-Mesenchymal Transition (EMT)-related markers, exhibited an increased expression of E-cadherin and a lower expression of N-cadherin in SNORD47-treated glioma cells (Figure 4C). This evidence concerns the gene CDH1 and central nervous system cancer.